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Endomitosis is the process by which mammalian megakaryocytes become polyploid during
terminal differentiation. As in other endoreplicating cells, cyclin-cdk complexes are distinctly
regulated, probably to overcome the strict mechanisms that prevent rereplication in most somatic
cells. We have asked whether key factors involved in the assembly and licensing of replication
origins are equally regulated during endomitosis. Cdc6, cdt1, and geminin expression was
analyzed during differentiation of two human megakaryoblastic cell lines, HEL and K562, which
respectively do and do not establish endoreplication cycles. Geminin was downregulated,
whereas cdt1 levels were maintained upon differentiation of both cell lines, independently of
whether cells entered extra S-phases. In contrast, cdc6 was present and remained nuclear only in
differentiated endoreplicating cells. Interestingly, cdc6 protein expression was reestablished in
K562 cells that underwent endomitosis after transient or stable cyclin E overexpression. The high
levels of cyclin E reached in these cells appeared to influence the stabilization of cdc6 protein
rather than its RNA transcription rate. Finally, cdc6 overexpression drove HEL cells into endorep-
lication cycles in the absence of differentiation stimuli. Our results show that both cdt1 and cdc6
are differentially regulated during megakaryocytic differentiation and suggest an active role of
cdc6 in endomitosis.
INTRODUCTION
In eukaryotic cells, DNA replication must be restricted to
once per cell cycle. However, some cell types, from plants to
mammals, physiologically become polyploid by establishing
rereplication cycles as part of their differentiation programs.
One of the few adult cell types with this peculiar feature is
the mammalian megakaryocyte. During final maturation
stages, megakaryocytes repeatedly replicate their nuclear
DNA and undergo an abortive mitosis that lacks karyo- and
cytokinesis, in a process traditionally known as endomitosis
(Nagata et al., 1997; Vitrat et al., 1998). It is conceivable that
in these cells, at least some of the processes involved in the
prevention of replication reinitiation must be altered.
The mechanisms that guarantee the strict alternation of S
and M phases within a mitotic cycle are remarkably con-
served from yeast to mammals. They comprise a finely
tuned interplay between cyclin-dependent kinases, respon-
sible for the proper progression through G1, S, G2, and M
phases, and protein complexes involved in building up and
licensing the origins of replication (for review, see Diffley
and Labib, 2002). During G1 phase, prereplication com-
plexes (pre-RC) are assembled, then origin firing is triggered
at the entrance into S phase, and once replication has been
initiated, origins remain silenced until daughter cells
progress onto the next G1 phase. At the end of mitosis,
assembly of prereplication complexes starts by separately
recruiting two factors, cdc6 and cdt1, to the origin recogni-
tion complex (ORC; Cocker et al., 1996; Coleman et al., 1996;
Blow and Tada, 2000; Maiorano et al., 2000; Nishitani et al.,
2000). ORC is formed by six distinct subunits, and their
binding to DNA determine, at least in part, the identity of
the replication origin (Quintana and Dutta, 1999). The bind-
ing of cdc6 and cdt1 is essential to form the pre-RC complex,
because they both promote the loading of the license com-
plex of mini-chromosome maintenance proteins, mcm 2–7
(Lei and Tye, 2001). MCM complexes are required both for
initiation and elongation phases, probably because of their
unwinding helicase activity at replication forks (Ishimi,
1997; Patel and Picha, 2000). The pre-RC is converted into a
preinitiation complex (pre-IC) by further recruiting of addi-
tional factors such as cdc45 and Dbf4-cdc7 complex (Leath-
erwood, 1998; Lei and Tye, 2001). Cdc7 kinase could be
responsible, together with cyclin E-cdk2, for triggering DNA
replication (Roberts et al., 1999; Sclafani, 2000). Cdc6 and
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cdt1 are only necessary for initiation, and it is believed that
they are released from the pre-IC at the onset of S phase
(Diffley and Labib, 2002). In metazoans, cdc6 is stable during
S phase. However, it is exported from the nucleus, probably
after being phosphorylated by cyclinA-cdk2 (Saha et al.,
1998; Findeisen et al., 1999; Jiang et al., 1999; Petersen et al.,
1999). Thus, cdc6 activity seems to be controlled through
G1/S cyclins-cdk complexes. In contrast, cdt1 activity ap-
pears to be regulated through interaction with geminin
(Wohlschlegel et al., 2000; Tada et al., 2001), a potent repli-
cation inhibitor the expression of which is regulated in a cell
cycle–dependent manner (McGarry and Kirschner, 1998;
Bastians et al., 1999). Cdt1 expression seems to remain con-
stant throughout the cell cycle (Nishitani et al., 2001),
whereas geminin is proteolysed via the APC/C complex
after onset of mitosis (McGarry and Kirschner, 1998). In this
way, cdt1-induced MCM binding can only take place in the
absence of geminin, i.e., from late mitosis to early S phase,
when geminin begins to be detected in proliferating cells
(McGarry and Kirschner, 1998; Nishitani et al., 2001).
Most biochemical studies aimed at understanding the mo-
lecular mechanisms by which megakaryocytes are able to
overcome rereplication restrictions have focused on whether
cyclin-cdk complexes are differentially regulated in endomi-
totic cells. In vitro and in vivo experimental approaches
have shown that both G1/S and G2/M cell cycle transitions
have to be regulated for megakaryocytes to achieve
polyploidization (for a recent review see Ravid et al., 2002).
For instance, both cyclins A and B are expressed and tem-
porally regulated as in a mitotic cycle (Datta et al., 1996;
Garcia and Cales, 1996; Vitrat et al., 1998; Garcia et al., 2000;
Bornstein et al., 2001). In contrast, both cyclinD3-cdk2, and
cyclinE-cdk2 complexes have been proposed as the most
likely candidates to drive megakaryocytic polyploidization
(Wang et al., 1995; Garcia and Cales, 1996; Matsumura et al.,
2000). Cyclin D3 expression is markedly higher in
megakaryocytes (Zimmet et al., 1997), and cyclin E appears
to be differentially regulated in megakaryocytic cells under-
going endoreplication cycles (Garcia and Cales, 1996; Datta
et al., 1998; Bornstein et al., 2001). In fact, cyclin E expression
is maintained in cells that have accomplished the endorep-
lication S phase, and when overexpressed, this cyclin is able
to drive nonendoreplicating megakaryoblastic cells into en-
domitosis (Garcia et al., 2000). It seems, therefore, that basal
cell cycle machinery is differentially controlled during
megakaryocytic endoreplication. However, the mechanisms
by which such cyclin-cdk alterations affect the replication
initiation machinery are unknown.
Our work was aimed at determining whether key factors
involved in both replication firing and refiring prevention are
differentially regulated during megakaryocytic endoreplica-
tion. Data are presented that show how cdc6, cdt1, and gemi-
nin are regulated in two megakaryoblastic cell lines, HEL and
K562, which have similar responses to differentiation stimulus
in terms of megakaryocytic differentiation, but only one of
which, the HEL cell line, acquires a polyploid phenotype.
MATERIALS AND METHODS
Cell Culture
HEL, K562, and derived HA1 and KEB cells were cultured in RPMI
1640 medium (Life Technologies, Paisley, UK) supplemented with
10% (vol/vol) fetal calf serum (BioWhitaker, Verviers, Belgium), 2
mM l-glutamine (Life Technologies) and 60 mg/ml gentamicin
(Normon Laboratories, Madrid, Spain). G418 antibiotic (Life Tech-
nologies) was added to HA1 and KEB cells culture medium to a
final concentration of 200 g/ml. HeLa cells were cultured in
DMEM (Life Technologies) medium supplemented with 10% (vol/
vol) fetal calf serum (Life Technologies), 100 U/ml penicillin, and
100 g/ml streptomycin (both from Life Technologies). Cells were
maintained at 37°C under 5% CO2/95% air in a humidified incuba-
tor. To induce megakaryocytic differentiation, 0.15–0.20  106 cells
per ml were grown in the presence or absence of 108 M o-tetra-
decanoylphorbol 13-acetate (TPA; Sigma, Madrid, Spain) for the
indicated times. For S-phase synchronization, HeLa cells were cul-
tured in the presence of 2.5 mM thymidine (Sigma, St. Louis, MO)
for 25 h, washed once with phosphate-buffered saline (PBS), and
then allowed to grow for an additional 2 h in fresh medium. For
metaphase synchronization, HeLa cells were cultured in presence of
nocodazol (Sigma) at 50 g/ml for 14 h.
Constructs and Oligonucleotides
For pMTcdc6, a 1.8-kb fragment encoding full-length human cdc6
cDNA was isolated by partial digestion with XhoI and XbaI from
pBSK-cdc6 and subcloned into pCS2MT (Rupp et al., 1994) multi-
cloning site in order to construct an myc-tagged form of the protein.
A 2-kb BamHI fragment was then subcloned into pLZR-CMV-IRES-
NGFR (Abad et al., 2002) in order to construct pLZR-cdc6. A 1.8-kb
BamHI/NotI fragment from pBS-GSTcdc6 5XA (Herbig et al., 2000)
encoding a phophorylation mutant of human cdc6 was subcloned
into pCDNA3.1 (Invitrogen, San Diego, CA), and an HindIII/XbaI
partially digested fragment from this plasmid subsequently was
inserted into pS72 vector (Promega, Madison, WI). A XhoI/XbaI
fragment was then inserted in the corresponding sites of pCS2MT to
obtain pMTcdc6–5xA.
For full-length human geminin cDNA cloning, the reverse tran-
scriptase polymerase (Promega) reaction was performed using total
RNA extracted from hydroxyurea-treated HeLa cells. cDNA was
amplified by PCR using Pfu-polymerase (Promega). 5ATGAATC-
CCAGTATGAAGCAG-3 and 5-CTTCGGCAGTAAAATTCT-
CAA-3 were used as upper and lower primers, respectively. The
resulting 0.7-kb amplimer was purified and subcloned into the
EcoRV site of pZEro-2.1 (Invitrogen). PGEX-cdt1 encoding full-
length human cdt1 cDNA was obtained from Dr. Dutta. pCDNA3-
cyclinE plasmid construction has been described elsewhere (Garcia
et al., 2000)
Northern Blot
Total RNA was extracted using TRIzol Reagent (Life Technologies),
following the procedure described by the manufacturer. RNA sam-
ples were denatured, electrophoresed in 1.1% agarose-formalde-
hyde gels containing 0.1 mg/ml ethidium bromide and blotted onto
nylon membranes (Hybond-N; Amersham, Barcelona, Spain).
Ethidium bromide (Sigma) staining of 28S and 18S rRNAs was
routinely checked before and after blotting as a control of sample
loading and RNA transfer, respectively. RNA blots were prehy-
bridyzed, then hybridyzed with excess (32P)-labeled probes, washed
under highly stringent conditions, and auto-radiographed. The fol-
lowing probes were used: 1.9-kb human cdc6 BamHI-SalI fragment
from pBSKcdc6 plasmid; 1.9-kb human cdt1 NotI-EcoRI fragment
from pGEX-cdt1; 0.7-kb human geminin NotI-PstI fragment from
pZErO-geminin, and the entire pTRI-RNA28S plasmid, which hy-
bridyzes to 28 S rRNA (Ambion Inc., Austin, TX). The fragments
were labeled to 109 cpm per g of DNA with [-32P]dCTP (3000
Ci/mmol; New England Nuclear, Boston, MA) using the Prime-It II
random priming labeling kit (Stratagene, La Jolla, CA).
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Transient Transfection and NGFR-positive Cell
Immunoselection
Five to 20 million cells were washed and resuspended in serum-free
RPMI medium before electroporation at 250 V and 975 Fd with 2
g of plasmid DNA per one million cells. After 10 min on ice, cells
were seeded in serum-supplemented medium. Cells were allowed
to recover for 12 h and then divided into two aliquots, one of which
was treated with TPA.
For pLZR-NGFR transfection experiments, cells were harvested
48 h after TPA treatment and washed in PBS/1%BSA. Before im-
munoselection, an aliquot from either control or cdc6-transfected
cells was incubated with anti-human NGFR (PharMingen, San Di-
ego, CA) and afterward with an anti-mouse FITC antibody (PharM-
ingen) to determine by flow cytometry the extent of NGFR expres-
sion (typically 5–10% of cells). For immunoselection, magnetic
beads conjugated to anti-mouse IgG through a DNA bridge (Dynal,
Oslo, Norway) were pretreated with anti-human NGFR for 15 min
at 4°C. Positive cells were then collected by magnetic selection with
the anti-NGFR–coupled beads, washed, and released by incubation
with a DNAse solution, according to the manufacturer’s instruc-
tions. Aliquots from whole cell population before immunoselection,
cells not bound to NGFR-beads, and DNAse-released cells (name-
ly, “whole population,” “negative cells,” and “positive cells,” re-
spectively) were collected, and DNA content was assessed by flow
cytometry.
Flow Cytometry Analysis of DNA Content
DNA content was determined by staining with 50 g/ml pro-
pidium iodide (Sigma) as previously described (Garcia and Cales,
1996). Cell cycle analysis was performed with a FACScan analyzer
and CellQuest software (Becton Dickinson).
Protein Extracts
Total cellular proteins were extracted in Lysis Buffer (20 mM Tris-
HCl, pH 7.4; 10 mM EDTA; 100 mM NaCl; 1% Triton X-100) con-
taining protease and phosphatase inhibitors. For phosphatase treat-
ment, 100 g of total protein was incubated with 25 U of calf
intestine alkaline phosphatase (CIAP; MBI Fermentas GmbH, St.
Leon-Rot, Germany) for 15 min at 30°C before being subjected to
SDS-PAGE. The reaction was stopped by adding Laemmli sample
buffer. For nuclear and cytoplasmic fractionation, cells were col-
lected, washed once with PBS and once again with hypotonic buffer
(20 mM HEPES, 5 mM potassium acetate, 500 nM MgCl2, and 500
nM DTT). After incubation in the hypotonic buffer for 10 min at 4°C,
cells were centrifuged for 5 min at 1800  g and resuspended in a
small volume of hypotonic buffer supplemented with protease and
phosphatase inhibitors. Cells were homogenized with a Dounce
homogenizer (loose pestle) and centrifuged for 5 min at 1800  g at
4°C in order to recover intact cell nuclei. Supernatant containing
cytoplasmic proteins was collected and centrifuged for 20 min at
16,000  g at 4°C. The nuclear pellet was washed once in hypotonic
buffer and then lysed in hypertonic buffer (20 mM HEPES, 5 mM
potassium acetate, 500 nM MgCl2, 500 nM DTT, and 400 mM NaCl)
for 1 h and 30 min at 4°C. The lysate was centrifuged and the
supernatant was collected. Total, nuclear, and cytoplasmic fractions
were snap-frozen and stored at 70°C until further analysis.
Western Blot Analysis
Protein extracts were subjected to SDS-PAGE and proteins trans-
ferred to BioTrace PVDF membranes (Pall Corporation, Ann Arbor,
MI) for 1 h at 2 mA/cm2 on a semidry transfer apparatus (Amer-
sham). Ponceau staining was routinely performed on membranes to
check sample loading control. After blocking in PBS containing 0.1%
Tween 20 (T-PBS) and 5% skimmed dry milk, filters were incubated
overnight at 4°C with the appropriate primary antibody diluted in
T-PBS. Antibodies used were as follows: anti-human cdc6 mouse
mAb (Ab3; Oncogene, Darmstadt, Germany) at a 1:500 dilution;
anti-human cdt1 rabbit polyclonal antibody (Nishitani et al., 2000) at
a 1:2500 dilution; anti-human geminin goat polyclonal antibody
(C-16; Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:1000 dilu-
tion; anti-human cyclin E mouse mAb (PharMingen) at a 1:1000
dilution; and anti-human cyclin A rabbit polyclonal antibody (Santa
Cruz Biotechnology) at a 1:1000 dilution. Anti-IB (C-21; Santa
Cruz Biotechnology) and anti-PCNA (Signet, Redham, MA) were
used as nuclear and cytoplasmic fractionation controls at 1:1000 and
1:2000 dilutions, respectively. Anti-heat shock transcription factor-1
(StressGen Biotechnologies Corp., Victoria, British Columbia, Can-
ada) was used at 1:2000 dilution as a positive control for CIAP
treatment. After washing and incubation with an appropriate sec-
ondary antibody conjugated to horseradish peroxidase (Dako,
Glostrup, Denmark), signals were detected using the enhanced
chemiluminescence system (Pierce, Rockford, IL).
Immunofluorescence Microscopy Analysis
After transfection with pCSMTcdc6 or pCSMT, KEB cells were
treated with 10[minoa]8M TPA for 48 h. Differentiated cells were then
collected, washed once with PBS and cytospun on to glass slides.
Cells were fixed in 4% paraformaldehyde in PBS for 10 min at room
temperature, permeabilized with 1% T-X100, and washed twice in
PBS. After quenching in 10 mM glycine for 10 min, cells were
incubated in blocking solution (2% BSA; 0,05% Tween 20 in PBS) for
1 h at RT and incubated with anti-human myc 9E10 epitope mAb
overnight at 4°C. After washing three times with 0.05% Tween 20 in
PBS, cells were incubated with a 1:200 dilution of anti-mouse Ig
conjugated to Alexa Fluor 488 (Molecular Probes Europe BV, Lei-
den, The Netherlands) in blocking solution for 1 h at room temper-
ature. After extensive washing with 0.05% Tween 20 in PBS, nuclei
were stained with 1 mg/ml DAPI for 5 min. After final washing,
preparations were treated with antifading Vectashield (VectorLabs,
Burlingame, CA) and examined under a confocal microscope (TCS-
SPII; Leica Microsystems Wetzlar GmbH, Wetzlar, Germany).
RESULTS
Cdc6 Expression Is Differentially Maintained in
Endoreplicating Cells
We first examined the steady state levels of cdc6, cdt1, and
geminin RNA in differentiated HEL and K562 cells. A
Northern blot analysis was carried out with total RNA from
exponentially growing or TPA-treated cells, using radiola-
beled human cdc6, cdt1, or geminin full-length cDNAs as a
probe. As seen in Figure 1A, the detected bands correspond-
ing to cdc6 transcripts (of 3.3 and 2.5 kb) reached slightly
higher levels in differentiated than in exponentially growing
HEL cells, whereas they significantly decreased in TPA-
treated, nonendoreplicating K562 cells when compared with
growing cells. On the other hand, the levels of cdt1 tran-
scripts (of 3 and 4 kb in size) decreased to similar levels in
both endoreplicating and nonendoreplicating cells (Figure
1B), and geminin transcript was profoundly downregulated
in both cell lines upon TPA treatment (Figure 1C). Thus, it
appears that only cdc6 expression was differentially regu-
lated in HEL versus K562 cells, because cdt1 and geminin
transcripts were downregulated upon differentiation of both
cell lines.
We wanted to confirm that the differential expression
pattern between HEL and K562 cells was also maintained at
the protein level. Western blot analysis was then performed
by incubating total protein extracts obtained from control
and TPA-treated HEL and K562 cells. It could be observed
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that whereas cdc6 was still present in differentiated HEL
cells (Figure 2A, lane 2), the protein could not be detected in
nonendoreplicating K562 extracts, at least in the same ex-
perimental conditions (Figure 2A, lane 6). To ascertain
whether the detected maintenance of cdc6 in HEL cells was
related to the establishment of endoreplication cycles, we
carried out similar experiments in cell lines derived from
HEL and K562 that have lost and gained, respectively, the
ability to undergo endomitosis (Figure 2B). In the case of
HA1 cells, these ectopically expressing Dmescargot HEL cells
do not establish endoreplication cycles in response to TPA
(Ballester et al., 2001; Figure 2B). Inversely, KEB have been
derived form K562 cells by constitutive expression of cyclin
E and are able to become polyploid when treated with the
differentiating agent (Garcia et al., 2000; Figure 2B). In KEB
cells, TPA treatment determines the stabilization of the ex-
ogenous cyclin E (Garcia et al., 2000; and as indicated in the
corresponding blot, Figure 2A). The Western blot analysis of
total protein extracts from growing and differentiated HA1
and KEB cells revealed that cdc6 was present in endorepli-
cating K562-derived KEB cells, whereas no protein could be
detected in TPA-treated HA1 cells extracts. The blots were
then reincubated with anti-cdt1 and antigeminin antibodies.
According to the TPA-driven downregulation of the corre-
sponding transcript shown in Figure 1C, no geminin was
detected in TPA-treated HEL and K562 cells or their deriv-
atives (Figure 2A). On the other hand, cdt1 was present in all
differentiated cells, except for escargot-expressing HA1 cells
(Figure 2A, lane 4). This could be related to a broad tran-
scriptional regulation by this repressor rather than to the
inability of these cells to undergo endoreplication, because
nonendoreplicating K562 cells showed cdt1 levels similar to
those found in HEL and KEB cells. Thus, it seems that the
presence of cdt1 during megakaryocytic differentiation is
due to stabilization of the protein, because in both TPA-
treated HEL and K562 cells the corresponding transcripts
were downregulated (Figure 1). It can also be noted that two
forms (apparent MW of 66 and 72 kDa) of the protein could
be detected. It has been described that cdt1 displays different
cell cycle–dependent mobilities (Nishitani et al., 2001). In
particular, it was shown that both S- and M-phase related
forms appeared to be retarded when compared with the
main 65-kDa G1 form (Nishitani et al., 2001). In our cells, the
minor, slower migrating band could be assigned to the S
phase form, as assessed by analysis of S- and M- arrested
HeLa cell extracts (see Figure 5). Interestingly, HEL cells
displayed a somewhat different pattern of cdt1 content, as
the S phase band was more prominent in these cells than in
K562, HA1, and KEB extracts, and actually increased in
TPA-treated cell extracts. Thus, this appeared to be unique
to HEL cells, and did not show any apparent relationship to
the ability to endoreplicate in the presence of differentiating
agent.
Figure 1. Cdc6 mRNA levels are upregulated
in endoreplicating megakaryoblastic cells. HEL
and K562 cells were cultured in the absence or
presence of 108 M TPA, and total RNA was
extracted. RNA, 20 g, from exponentially
growing cells () or cells treated with TPA for
48 h () was analyzed by Northern blotting
with full-length cdc6 (A), cdt1 (B) and geminin
(C) cDNAs as probes. The same blots incu-
bated with a probe recognizing 28S ribosomic
RNA are shown as a loading control (note that the blot analyzed with geminin probe was the same used for cdc6 mRNA detection, after
washing and rehybridization).
Figure 2. Cdc6 protein levels are only detected in differentiated
endoreplicating megakaryoblastic cells. (A) Exponentially growing
() and TPA-treated () HEL, HA1 (Dmescargot-expressing HEL-
derived line), K562 and KEB (cyclin E-overexpressing K562-derived
line) cells were collected, and whole protein extracts were obtained.
Total protein, 30 g, was subjected to SDS-PAGE and detected by
Western blotting with anti-cdc6, -cdt1, -geminin, and -cyclin E an-
tibodies. A portion of total protein staining of transferred gel is
shown as a loading control. Asterisk marks the faster migrating
cyclin E bands, which correspond to the protein overexpressed in
KEB cells. (B) DNA content pattern of these cells is shown as
analyzed by flow cytometry. Vertical axis, relative number of cells;
horizontal axis, relative red fluorescence (FL2) in a logarithmic scale,
indicating DNA content per cell. The positions of peaks represent-
ing cells with a DNA content equal to 2C, 4C, 8C, and 16C are
indicated. The ability of these cells to achieve (), or not (),
polyploid DNA content is indicated.
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These results suggest that megakaryocytic endomitosis is
characterized by the maintenance of cdc6 and cdt1 protein
expression, together with the downregulation of geminin.
However, only the presence/absence of cdc6 can be related
to the ability/inability of megakaryoblastic cells to undergo
endomitosis, because geminin and cdt1 did not show a
differential regulation pattern in endoreplicating and non-
endoreplicating cells.
Cdc6 Stabilization Is Concomitant to the
Establishment of the First Endoreplication Cycle,
whereas Geminin Downregulation Takes Place
Earlier
A high proportion of polyploid HEL or KEB cells is effec-
tively detected from 2 days after TPA treatment onward,
although changes in the expression pattern of regulatory cell
cycle factors take place much earlier after treatment with the
differentiation signal (Garcia et al., 2000; Ballester et al., 2001).
We thus asked whether cdc6 and geminin expression could
be subjected to short-term regulation in endoreplicating ver-
sus nonendoreplicating cells. Time-course Western blot
analysis was then performed at 4, 8, 15, and 24 h after TPA
treatment of HEL and K562 cells.
As can be seen in Figure 3, cdc6 was slightly upregulated
in both HEL and K562 cells during the first 4 h of differen-
tiation. However, from this time point onward, the protein
levels were found to be differentially regulated. In K562
cells, cdc6 levels diminished at 8- and 15-h time points and
became nearly undetectable 24 h after TPA treatment. In
contrast, cdc6 protein was still present in HEL cells at the
15-h time point and also 24 h after TPA treatment, at levels
similar to those found after longer treatments (Figure 2A).
Such different behavior between the cell lines was more
apparent in an extended time-course analysis of the timing
of cdc6 downregulation in K562 cells, i.e., from 15 to 24 h. As
shown in Figure 3C, cdc6 levels gradually diminished in
K562 cells from 16 h up to 32 h after TPA treatment but
remained unchanged in HEL cells during this time. It is
interesting to note that from 8 h onward, a significant num-
ber of HEL cells started to show DNA contents equal to or
higher than 4N, thus suggesting the starting point of en-
domitotic cycles. Cdc6 levels and the onset of endoreplica-
tion followed a similar pattern in TPA-treated KEB cells
(unpublished data). At this time point (8 h), cyclin E ap-
peared also to be downregulated in HEL cells, although its
expression was restored to levels similar to those found in
exponentially growing cells as cells proceeded to endorep-
lication.
On the other hand, geminin levels remained unchanged
up to 4 h in both HEL and K562 cells but were dramatically
downregulated after this time, independently of the ability
of cells to undergo endomitotic cycles. It can then be noted
that geminin was absent at the time HEL cells started to
undergo endomitotic cycles. Cdt1 levels did not change
during the time analyzed in HEL nor K562 cells (unpub-
lished data).
Altogether, these results suggest that the differences in
cdc6 expression observed between endoreplicating and non-
endoreplicating cells 2 days after differentiation induction
are detectable as early as 8 h after TPA treatment. They also
indicate that this time point broadly parallels the time of
establishment of endomitotic cycles and that geminin is
already absent at this point.
Cdc6 Is Present in Nuclear Compartment Only in
Endoreplicating Cells
We then wanted to determine cdc6 subcellular localization
in cells undergoing endoreplication cycles. Western blot
analysis was performed on nuclear and cytoplasmic protein
extracts obtained from HEL, HA1, K562, and KEB cells
untreated and treated with TPA for 48 h. Cell fractionation
was assessed by immunodetection of cytoplasmic (IB)
and nuclear (PCNA) proteins (Figure 4A). As expected, cdc6
levels were barely detected in nuclear and cytoplasmic ex-
tracts of nonendoreplicating TPA-treated K562 and HA1
cells (Figure 4A). In contrast, nuclear cdc6 was maintained in
Figure 3. Cdc6 stabilization is concomitant
with the establishment of the first endoreplica-
tion cycle. Whole protein extracts from HEL (A)
and K562 (B) cells were obtained before treat-
ment (0 h) or at 4, 8, 15, or 24 h after differen-
tiation induction. Total protein, 30 g, was sub-
jected to SDS-PAGE and detected by Western
blotting with anti-cdc6, -geminin, and -cyclin E
antibodies. A portion of the total protein stain-
ing of transferred gel is shown as a loading
control. Flow cytometry analysis of HEL and
K562 DNA content is shown. (C) An identical
experiment performed with extracts obtained
form HEL and K562 cells at the indicated times
after TPA treatment.
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endoreplicating HEL and KEB cells, whereas the levels of
cytoplasmic protein were concomitantly downregulated.
Also, the levels of nuclear cyclins E and A were higher in
endoreplicating HEL and KEB extracts than in TPA-treated
K562 and HA1 cells.
When cdt1 distribution was analyzed, we observed that a
large proportion of the protein remained nuclear in TPA-
treated HEL cells (Figure 4B). Similarly to what we found
when total extracts were used (see Figure 1A), the slower
migrating form of the protein was more prominent in dif-
ferentiated than in exponentially growing cells. Also, it
could be seen that this form was mainly located in the
cytoplasmic fraction of TPA-treated cells. Although KEB
cells showed an overall higher nuclear cdt1 content than
K562 cells, the relative levels were unchanged after TPA
treatment, and the protein remained nuclear in both differ-
entiated cells. No slower migrating form could be detected
in these cells. As expected, no geminin was present in the
extracts from differentiated HEL, K562, and KEB cells.
To characterize the extra cdt1 band detected in TPA-
treated HEL cells, we performed Western blot analysis of
total protein extracts from cells exponentially growing and
after 48 and 96 h of TPA treatment. As seen in Figure 5A, the
slower migrating form accumulated over the experiment
time course and was the major form detected after 4 d of
differentiation, when cells are still undergoing polyploidiza-
tion (see DNA content analysis). This result was also ob-
tained when a different polyclonal antibody was tested (Fig-
ure 5A, Ab3 blot). This band was identified as the form most
abundantly expressed in S-phase cells, because it comigrated
with the major band present in extracts from thymidine-
treated, S-phase synchronized HeLa cells (Figure 5B, lanes 1
and 2). It also appeared to be clearly distinguishable from
the mitotic, even-slower migrating form seen in nocodazol-
treated HeLa extracts (Figure 5B, lane 3). To determine
whether this mobility shift was due to a different phosphor-
ylation state, TPA-treated HEL extracts were incubated with
CIAP before SDS-PAGE electrophoresis. As can be seen in
Figure 5C, no change in the pattern of cdt1 bands could be
detected after enzymatic treatment. As an unrelated phos-
phoprotein, i.e., heat shock factor 1 (HSF-1), responded to
CIAP treatment, this result suggests that the mobility shift of
the cdt1 S-phase–related form was not due to phosphoryla-
tion. It cannot be discarded, however, that putative phos-
phorylated sites are not accessible to this enzyme or that
they could preferentially be recognized by other phospha-
tases.
Altogether, these results show that both cdt1 and cdc6 re-
main nuclear in HEL and KEB cells undergoing endoreplica-
tion. They also indicate that the only apparent difference be-
tween K562 cells and KEB cells, their cyclin E–overexpressing
derivatives, lies in a differential regulation of cdc6 expression.
Cdc6 Is Stabilized in Endoreplicating K562 Cells
with High Levels of Cyclin E
To investigate if cyclin E overexpression in KEB cells was
determining the maintenance of cdc6 at RNA or protein
Figure 4. Nuclear cdc6 levels are maintained in en-
doreplicating megakaryoblastic cells. (A) Exponen-
tially growing () and 48-h TPA-treated () HEL,
HA1, K562, and KEB cells were collected. Protein from
nuclear and cytoplasmic fractions was extracted. Nu-
clear or cytoplasmic total protein, 100 g, was sub-
jected to SDS-PAGE and detected by Western blotting
with anti-cdc6, -cyclin A, and -cyclin E antibodies.
Blots were stripped and reincubated with anti-PCNA
and I 75 B antibodies to assess the purity of sub-
cellular fractions. (B) Exponentially growing () or
TPA-treated () HEL cells were collected. Cdt1 and
geminin expression was detected by Western blot in
both nuclear (Nuc) and cytoplasmatic (Cyt) fractions.
(C) Nuclear and cytoplasmic protein extracts from
exponentially growing () or differentiated () K562
and KEB cells were analyzed by Western blotting with
anti-cdt1 and -geminin antibodies. Portions of the total
protein staining of transferred gels are shown as load-
ing controls.
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level, we first examined the levels of cdc6 transcripts in these
K562-derived cells. As shown in Figure 6A, the levels of cdc6
RNA were not upregulated by cyclin E overexpression, as
they slightly diminished in TPA-treated KEB cells. Then, in
order to further assess whether cyclin E overexpression was
influencing protein stability, we asked how an exogenous,
CMV promoter-driven tagged form of cdc6 would be af-
fected in these cells.
Both KEB and parental K562 cells were transiently trans-
fected with a myc-tagged human cdc6 protein encoding
plasmid (pMT-cdc6) or the empty vector (pMT), and either
treated with TPA for 48 h or left to grow exponentially over
the same time period. Whole cell extracts were obtained and
analyzed by Western blotting with anticdc6 (results shown
in Figure 6) and myc-tag 9E10 epitope antibodies, to confirm
the identity of the exogenous, myc-tagged protein (unpub-
lished data). Surprisingly, no ectopic cdc6 could be seen in
exponentially growing pMT-cdc6 transfected K562 cells
(Figure 6B, lane 6), and myc-tagged cdc6 protein could be
faintly detected in these cells only over a long film exposure,
and only after TPA treatment (see overexposed blot in the
Figure 6). In contrast, myc-tagged protein was present at
high levels in TPA-treated KEB cells (Figure 6B, lane 12) and
to a much lesser extent in exponentially growing cells, as can
be seen in the overexposed blot. Thus, the exogenous protein
reached higher expression levels after TPA treatment in
cyclin E–overexpressing cells. To determine whether the
stabilized myc-tagged protein was located in the nuclear
compartment, KEB cells transfected with pMT-cdc6 or pMT
were cytospun, incubated with the anti-myc 9E10 epitope
antibody or an isotype control, and analyzed by confocal
microscopy. It could be seen that only pMT-cdc6–trans-
fected cells were labeled with the anti-myc antibody.
Whereas exponentially growing cells were faintly positive
(unpublished data), myc-tagged cdc6 was clearly detected in
the nuclei of a higher percentage of TPA-treated KEB cells,
as shown in a representative projection of the captured
images (Figure 6C). These results suggest that the stabiliza-
tion of constitutively expressed myc-tagged cdc6 protein is
related to the high cyclin E levels reached in TPA-treated
KEB cells.
To confirm this hypothesis, K562 cells were transiently
cotransfected with an expression vector containing cyclin E
cDNA (pcDNA3-cycE) and pMT-cdc6, pcDNA3-cycE and
empty pMT or empty pcDNA3 and pMT-cdc6. We have
previously shown that transient expression of cyclin E is
able to drive K562 cells into endoreplication cycles after TPA
treatment (Garcia et al., 2000). When Western blot analysis
was carried out to assess cdc6 expression, it could be ob-
served that myc-tagged cdc6 levels significantly increased in
the TPA-treated cells, thus overexpressing cyclin E (Figure
6D, compare lanes 6 and 8). In fact, in nonoverexposed blots,
the only fraction in which the protein could be detected
corresponded to TPA-treated cotransfected cells (unpub-
lished data). Interestingly, when cells were transfected with
a nonfunctional cdc6 mutant form that is unphosphorytal-
able by cyclin-cdk complexes (Herbig et al., 2000), it could be
seen that this cyclin E–related stabilization did occur with
much lower efficiency (Figure 6E, compare lanes 4 and 5).
Altogether, these results indicate that overexpression of
cyclin E in K562 cells results in the maintenance of cdc6,
mainly through the stabilization of the nuclear protein and
that this requires intact cdk phosphorylation sites. This sug-
gests that endoreplication in KEB cells is due to the accu-
mulation of both functional cyclin E and cdc6.
Cdc6 Is Able to Drive HEL Cells into an
Endoreplication Cycle
We next asked whether cdc6 could have a direct role in the
establishment of new rounds of DNA synthesis in HEL cells.
For this purpose, HEL cells were transiently transfected with
a retroviral bicistronic vector containing cdc6 and a trun-
cated form of neural growth factor receptor (-NGFR) cD-
NAs downstream of an IRES sequence that allows the trans-
lation of both proteins from a single transcript (Abad et al.,
2002). The expression of the bicistron was under CMV pro-
moter control. Because -NGFR is directed to the cell surface
but lacks any downstream activity, it serves as a means of
isolating transfected cells by use of immunomagnetic de-
vices.
HEL cells were transfected with the vector containing
cdc6-IRES--NGFR or IRES--NGFR only (hereafter re-
ferred as to “cdc6” and “control,” respectively) and then
stimulated with TPA for 48 h or allowed to grow exponen-
tially in culture medium for the same time period. Before
proceeding to their separation, their DNA content was mea-
sured and found to be identical in cdc6- and control-trans-
fected cells (Figure 7, whole population). Cells were then
Figure 5. A slower migrating form of cdt1 is stabilized in endorep-
licating HEL cells. Total protein extracts from HEL cells untreated (0
h) or treated with TPA for 48 and 96 h were subjected to SDS-PAGE
and analyzed by Western blotting for cdt1 expression with two
independent anti-cdt1 polyclonal antibodies (Ab2 and Ab3). (B)
Total protein extracts from S- and M-phase synchronized HeLa cells
(lanes 2 and 3, respectively) and cytoplasmic protein extract form
HEL cells treated with TPA for 96 h were analyzed with anti-cdt1
polyclonal antibody Ab2. (C) Total protein extract from TPA-treated
HEL cells (HEL TPA) was incubated with calf intestine alkaline
phosphatase (CIAP) or with buffer only (Buffer) for 15 min at 30°C.
HeLa cells subjected to heat-shock at 42°C for 1 h (HeLa HS) were
used to detect heat shock factor 1 (HSF-1) phosphorylation. Phos-
phatase reaction was performed in total protein extracts form these
cells as a control of CIAP activity. Portions of the total protein
staining of transferred gels are shown as loading controls. Arrows
indicate the different migrating cdt1 forms.
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labeled with the anti-NGFR mAb. -NGFR–expressing cells
(transfected) were then separated from -NGFR–nonex-
pressing (nontransfected) cells by incubation with anti-
mouse Ig coupled to magnetic beads. Both populations
(NGFR-positive; NGFR-negative) were collected and their
DNA content analyzed by flow cytometry. As can be seen in
Figure 7, all treated cells responded to TPA as expected and
underwent at least one endoreplication cycle. This was in-
dependent of whether they were expressing the ectopic pro-
teins (NGFR-positive cells) or not (NGFR-negative cells) and
in the case of NGFR-positive cells, whether they contained
cdc6 or vector only. No apparent effect of cdc6 overexpres-
sion could be detected, in terms of further potentiation of
TPA-driven endoreplication. However, exponentially grow-
ing HEL cells that had been transfected with cdc6 presented
a nearly identical DNA content pattern to that of the TPA-
treated cells. This phenotype (endoreplication in the absence
of a differentiation stimulus) was only detected in cdc6-
expressing cells, because both the NGFR-negative cdc6-
transfected cells and NGFR-positive cells transfected with
vector only had the typical DNA content pattern corre-
sponding to exponentially growing cells.
These results indicate that ectopic expression of cdc6 is
able to promote by itself the endoreplication in HEL cells to
a comparable degree to that reached after TPA treatment
DISCUSSION
Megakaryocytic endomitosis represents a valuable system
for the study of how mammalian cells are able to overcome
the strict rereplication restrictions imposed to most somatic
Figure 6. Cdc6 is stabilized in K562
cells with high levels of cyclin E. (A) KEB
cells were cultured for 48 h in the ab-
sence () or the presence () of TPA and
total RNA was extracted. RNA, 20 g,
was analyzed by Northern blot with full-
length cdc6 cDNA as a probe. The same
blot was incubated with a probe recog-
nizing 28S ribosomic RNA and is shown
as a loading control. (B) K562 and KEB
cells were transiently transfected with
either pMT or pMTcdc6 plasmids. Non-
transfected, pMT-transfected, and
pMTcdc6-transfected cells were allowed
to grow exponentially () or treated
with TPA for 48 h (). Whole protein
fractions were obtained, and Western
blot analysis with anticdc6 antibody was
performed. An overexposed film is also
shown to stress the limited expression of
myc-tagged cdc6. (C) pMTcdc6-trans-
fected KEB cells, 2  104, were cytospun,
fixed with formaldehyde, permeabilized
with TX100, and incubated sequentially
with anti-myc 9E10 and Alexa Fluor
488–conjugated anti-mouse Ig antibod-
ies. Nuclei were counterstained with
DAPI. The figure shows the maximal
projection (blue, green, and merge) of an
image at 1024  1024 resolution. (D)
K562 cells were transiently cotransfected
with pMTcdc6 and pcDNA-cycE or the
corresponding empty plasmids. Either
exponentially growing () or TPA-
treated () cells were analyzed by West-
ern blot using anti-cdc6 and -cyclin E
antibodies. (E) Western blot analysis
with anti-cdc6 and -cyclin E antibodies
of TPA-treated pMT-, pMT-cdc6 wild-
type (pMTwt)- or pMT- cdc6 5xA mu-
tant (pMT5xA)-transfected cells, and
cells cotransfected with pMTwt or
pMT5xA plasmids, together with
pCDNA-cyclin E are shown. Portions of
the total protein staining of transferred
gels are shown as loading controls. Both
D and E show overexposed blots.
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cells. By comparing two megakaryoblastic cell lines that
both undergo megakaryocytic differentiation upon TPA
treatment but display different abilities to become polyploid,
we have found that the basic DNA replication initiation
machinery is differentially regulated during endoreplica-
tion. We have shown that the differentiation stimulus deter-
mines geminin downregulation, together with cdt1 stabili-
zation. Also, cdc6 is stabilized only in endoreplicating cells,
and cyclin E may play an important role in such stabiliza-
tion. Finally, we show that ectopic cdc6 expression in
megakaryoblastic cells fully determined to become
polyploid provokes the entrance into endomitosis in the
absence of differentiation stimuli.
Geminin Downregulation Is Concomitant with
Megakaryocytic Differentiation
Geminin was first described as a potent inhibitor of DNA
replication and as a neutralizing molecule during Xenopus
development (Kroll et al., 1998; McGarry and Kirschner,
1998). Interestingly, recent reports have independently
shown that geminin avidly binds to cdt1 (Wohlschlegel et al.,
2000; Tada et al., 2001). Indeed, it has been proposed to be
one of the mechanisms that ensures the silencing of already
fired origins until completion of the entire cycle (Lygerou
and Nurse, 2000). Geminin is expressed from S phase to the
onset of mitosis, when it becomes degraded via the APC/C
system (McGarry and Kirschner, 1998). Therefore, one could
expect that this mechanism would also be operative in
megakaryocytic endomitosis, as cells transit normally from
metaphase to anaphase, only skipping subsequent mitotic
steps (Nagata et al., 1997; Vitrat et al., 1998). However, our
results show that geminin is significantly downregulated in
megakaryocytic cells, soon after being stimulated to differ-
entiate, and independently of whether the cells further es-
tablish endoreplication cycles.
As geminin has been proposed to play an important role
in determining neural cell fate (Kroll et al., 1998; Quinn et al.,
2001), it has been hypothesized that an increase of geminin
expression could help differentiating cells to withdraw from
the cell cycle (Madine and Laskey, 2001). High levels of
geminin would thus be expected upon any differentiation
stimulus. Obviously, this is not the case in megakaryocytes.
The simplest interpretation is that the differentiation-driven
downregulation of geminin would be a necessary event for
allowing these particular cells to complete their differentia-
tion program, ultimately and uniquely necessitating an es-
cape from rereplication control. Genetic experiments in Dro-
sophila embryos and cultured cells have shown that silencing
of geminin provokes actual overreplication (Quinn et al.,
2001; Mihaylov et al., 2002). It could then be inferred that
geminin downregulation is a requirement for cells to en-
doreplicate. However, Drosophila geminin appears to be nor-
mally expressed in endoreplicating tissues of the gut and in
adult ovarian nurse and follicle cells (Quinn et al., 2001). One
possible explanation for this apparent discrepancy between
megakaryocytes and insect cells could lie on the fundamen-
tal differences between the endocycles of these Drosophila
cells and megakaryocytic endoreplication. As mentioned
Figure 7. Cdc6 is able to drive proliferating HEL
cells into the endoreplication cycle. HEL cells were
transiently transfected with pLZR-CMV-IRES-
NGFR empty vector (control) or pLZR-CMV-cdc6-
IRES-NGFR construct (cdc6) and allowed to grow
exponentially () or treated with TPA for 48 h ().
DNA content of whole population, NGFR-positive,
and NGFR-negative immunoselected cells was ana-
lyzed by flow cytometry. Arrows indicate the posi-
tion of 2C, 4C, and 8C DNA content cell peaks. The
histograms shown are representative of four inde-
pendent experiments.
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above, the latter actually comprises early mitotic stages (Na-
gata et al., 1997; Vitrat et al., 1998), whereas the former skip the
G2/M transition (Lilly and Spradling, 1996). Hence, it would
be interesting to explore whether the silencing of geminin has
any additional meaning in the context of the abortive mitosis
that takes place in megakaryocytes. In this respect, it has been
proposed that geminin could have a role in anaphase, at some
stage after cyclin B degradation (Quinn et al., 2001). Cyclin B
degradation also occurs in endomitotic cycles, so it is tempting
to speculate that at this point the absence of geminin could at
least be one of the events that prevent completion of anaphase
in differentiated megakaryocytes.
Cdc6 Is Specifically Maintained in Differentiated
Megakaryoblastic Cells that Become Polyploid
Our data clearly show that the main difference between
endoreplicating and nonendoreplicating megakaryocytic
cells lies in the presence of cdc6, because in nonendorepli-
cating cells its expression is severely compromised. In an
unrelated cell system such as Arabidopsis endoreplicating
cells, cdc6 expression has also been found to be maintained
(Castellano et al., 2001; Ramos et al., 2001). In one of these
reports, the authors propose that the maintenance of cdc6
levels in dark-grown hypocotolyl cells is assured both by
active gene expression and protein stabilization (Castellano
et al., 2001). Our data suggest that in megakaryocytes these
mechanisms can also account for the continuous presence of
the protein. Thus, in endoreplicating TPA-treated HEL cells,
the RNA levels of cdc6 are maintained and even increased
long after endoreplication cycles have been established,
whereas they are downregulated in K562 cells. Additionally,
our data strongly suggest that stabilization of the protein can
be a second mechanism by which cdc6 is maintained in
endoreplicating cells. First, not only are cdc6 levels main-
tained in HEL; a particularly high proportion of the protein
remains nuclear. Second, endoreplication of cyclin E–over-
expressing K562 cells results in the presence of the nuclear
protein, with no major stimulation of cdc6 transcripts levels.
Thus, it can be suggested that megakaryocytic endoreplica-
tion involves specific regulation of both transcription and
stabilization of the protein.
Cyclin E Is Responsible for cdc6 Stabilization in
Endoreplicating Cells
One interesting observation in this article is that cyclin E
appears to contribute to cdc6 stabilization during
megakaryocytic endoreplication. Cdc6 protein is detected in
TPA-treated K562 cells that become competent to undergo
polyploidization by stably overexpressing cyclin E (KEB cell
line). This could be interpreted as a nonspecific effect of
cyclin E induction of the expression of G1/S downstream
regulators, i.e., cyclin A (Zerfass-Thome et al., 1997; Garcia et
al., 2000). Thus, it could simply be due to an increased
transcription rate, as a consequence of cells being able to
proceed through G1 and on to S, because cdc6 expression
seems to be controlled through E2F (Hateboer et al., 1998;
Ohtani et al., 1998; Yan et al., 1998). However, our results
suggest a direct role for cyclin E in cdc6 protein stabilization.
First, cdc6 steady-state RNA decreased in differentiated KEB
and did not reach the levels present in endoreplicating HEL
cells, indicating that overexpressed cyclin E is not inducing
cdc6 expression. Second, the stabilization of total cdc6 pro-
tein paralleled the establishment of endoreplication and cy-
clin E stabilization, and its preferential nuclear localization is
coincident with that of cyclin E (this article and Garcia et al.,
2000). Third, an exogenous myc-tagged cdc6 protein, whose
expression was not dependent on cell cycle progression,
could only be detected in TPA-treated KEB cells and also in
TPA-treated, cyclin E-transiently transfected K562 cells.
To our knowledge, this is the first time that such a rela-
tionship between cyclin E and cdc6 has been observed. It is
noteworthy that the pattern of expression and cellular local-
ization of both proteins are strikingly coincident in mitotic,
and also in endomitotic, cycles (this article; Koff et al., 1991;
Dulic et al., 1992; Garcia and Cales, 1996; Garcia et al., 2000).
Also, cdc6 and cyclin E appear to have a synergistic effect on
inducing S-phase entry of cotransfected cells (Hateboer et al.,
1998) as well as in a cell-free system (Coverley et al., 2002). A
direct role for cdc6 as a chromatin anchor for the cyclin
E-cdk2 complex has even been proposed (Furstenthal et al.,
2001). It can thus be speculated that both proteins stably
interact whenever they coincide spatiotemporally. In a reg-
ular mitotic cycle, cyclin E and cdc6 levels peak at the G1/S
transition and coincidentally increase in the nucleus around
that time. However, shortly after S phase onset, cyclin E is
proteolysed and only starts to accumulate after completion
of mitosis. So, if an interaction between cdc6 and cyclin E
does occur, it can only take place within a narrow time
window in proliferating cells. In contrast, in megakaryocytic
cells undergoing endomitosis, high levels of cyclin E persist
throughout the process, probably reflecting a specific regu-
latory mechanism (Garcia and Cales, 1996; Datta et al., 1998;
Garcia et al., 2000). It could be argued that cyclin E perma-
nence in the nucleus after completion of endomitotic S phase
could in turn influence cdc6 stabilization. A similar situa-
tion, e.g., polyploidization related to stabilization of cyclin E
beyond S-phase, has been observed in another mammalian
cell type. In skp2/ mice hepatocytes, the silencing of this
component of the ubiquitin-ligase complex SCF determines
cyclin E stabilization and the potentiation of endoreplication
of these cells not only in vitro (Nakayama et al., 2000), but
also “in vivo” (Minamishima and Nakayama, 2002). It
would be interesting to explore whether cdc6 is equally
stabilized in these endoreplicating hepatocytes.
Cdc6 Is Able to Drive Proliferating HEL Cells into
Endomitotic Cycles
A striking observation of this article is that transient expression
of cdc6 is able to drive endoreplication in proliferating HEL
cells. This effect is reminiscent of earlier reports on other cell
types such as Schizosaccharomyces pombe (Nishitani and Nurse,
1995) and more recently in Arabidopsis thaliana (Castellano et al.,
2001). However, the mechanism by which high levels of cdc6
are able to trigger the entrance into extra S-phases has not been
elucidated to date. Interestingly, Saccharomyces cerevisiae cdc6
inhibits mitotic cdk activity, thus delaying the progression into
mitosis (Calzada et al., 2001; Weinreich et al., 2001). If this were
a conserved action of cdc6, it would be possible that in HEL
and A. thaliana cells a cdc6-mediated delay in G2/M transition,
together with its licensing function, would facilitate origin re-
licensing and hence the entrance into endoreplication cycles. In
fact, some megakaryoblastic cells become polyploid when mi-
tosis progression is inhibited by nocodazol treatment (van der
R. Bermejo et al.
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Loo et al., 1993). However, cdc6 overexpression was not able on
its own to drive K562 nor KEB cells into endoreplication (R.B.,
N.V., and C.C., unpublished results). This has led us to think
that cdc6 mitotic inhibition cannot be the sole explanation of
how cdc6 is driving proliferating HEL cells into polyploidiza-
tion. Actually, cdc6 overexpression does not provoke endorep-
lication in S. cerevisiae (Drury et al., 1997) or other mammalian
cells (Ohtani et al., 1998; Petersen et al., 2000). Our interpretation
is that only cells determined to establish endoreplication cycles
will respond to cdc6 overexpression. This would be the case for
HEL cells, in contrast with K562 cells, which correspond to cells
with a more undifferentiated phenotype. It can be speculated
that in cells developmentally prone to endoreplicate, i.e., HEL
or physiologically endoreplicating A. thaliana cells, additional
factors might be present that synergize with overexpressed
cdc6. Intriguingly, cdt1 appears to be differentially regulated in
HEL cells. A stabilized S-phase form, expressed at low levels in
proliferating cells, was found to be uniquely upregulated dur-
ing HEL endoreplication. Furthermore, this form was more
prominent in exponentially growing HEL than in K562 or KEB
cells. We could hypothesize that this differential feature reflects
the readiness of HEL cells to endoreplicate. If this were the
case, it could be that a particularly high proportion of both cdc6
and S-phase stabilized cdt1 coincide in cdc6-transfected HEL
cells. This synergy between cdt1 and cdc6 would be responsi-
ble for origin licensing and entrance into extra S phases. This
situation is reminiscent to the rereplication that takes place in
Xenopus sperm nuclei when cdk activity and geminin are
blocked in metaphase extracts (Tada et al., 1999) or in S. pombe,
when both cdc6 and cdt1 are overexpressed in G2 phase
(Yanow et al., 2001).
In conclusion, we have shown that megakaryocytic differ-
entiation determines the downregulation of geminin but
that endoreplication is only allowed when both cdc6 and
cdt1 expression are stabilized
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